Milestones in our drug discovery efforts

 

Current projects at Microbial Novoteqs focus on the search for inhibitors of proteases necessary for pathogenic virus replication , broad-spectrum fungicides active against fungi pathogenic to humans, and inhibitors of bacterial toxins that pose threats as biological weapons. Significant progress has been made towards achieving our long-term goal of producing clinically safe and effective drugs against these targets. Our microbial cell-based assay technology allows accelerated hit generation with the addition of pharmacological filters such as cell permeability and cytotoxicity of test compounds, thus rapidly moving promising drug candidates through the pipeline.

 

 

Company  News & Events  Global Health  Green Energy  Yeast-Based Technologies  Management  Contact Us

Copyright © 2007-2009 Microbial Novoteqs, Inc.,  All Rights Reserved.